Uterine artery velocity waveforms as predictors of pregnancy outcome in patients with antiphospholipid syndrome: A review

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 530-539

  De Carolis, Sara ^a   Botta, Angela ^a   Garofalo, Serafina ^a   Ferrazzani, Sergio ^a   Martino, Carmelinda ^a   Fatigante, Gabriella ^a   Caforio, Leonardo ^a   Caruso, Alessandro ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antiphospholipid syndrome; Pregnancy outcome; Uterine artery Doppler velocimetry

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PREDNISONE;

ANTIPHOSPHOLIPID SYNDROME; BLOOD FLOW; COLOR ULTRASOUND FLOWMETRY; COMBINATION CHEMOTHERAPY; CONFERENCE PAPER; HUMAN; INTRAUTERINE GROWTH RETARDATION; MONOTHERAPY; PLACENTA CIRCULATION; PLACENTA INSUFFICIENCY; PREDICTION; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; THROMBOSIS PREVENTION; UTERINE ARTERY; VELOCITY; WAVEFORM;

EID: 34948819659     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.056     Document Type: Conference Paper

References (24)

1. WILSON, W.A. 2001. Classification criteria for antiphospholipid syndrome. Rheum. Dis. Clin. North Am. 27: 499-505.
2. BACKOS, M., R. RAI, N. BAXTER, et al. 1999. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br. J. Obstet. Gynaecol. 106: 102-107.
3. DE WOLF, F., L.O. CARRERAS, P. MOERNA, et al. 1982. Decidual vasculopathy an extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss and a lupus anticoagulant. Am. J. Obstet. Gynecol. 142: 829-834.
4. BRANCH, D.W. 2004. Antiphospholipid syndrome and fetal compromise. Thromb. Res. 114: 415-418.
5. RAND, J.H., X.X. WU, S. GULLER, et al. 1997. Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. Am. J. Obstet. Gynecol. 177: 918-923.
6. CHAMLEY, L.W., A.M. DUNCALF, M.D. MITCHELL, et al. 1998. Action of anticardiolipin and antibodies to beta2-glycoprotein-I on trophoblast proliferation as a mechanism for fetal death. Lancet 352: 1037-1038.
7. LYDEN, T.W., E. VOGT, A.K. NG, et al. 1992. Monoclonal antiphospholipid antibody reactivity against human placental trophoblast. J. Reprod. Immunol. 22: 1-14.
8. SEBIRE, N.J., H. FOX, M. BACKOS, et al. 2002. Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum. Reprod. 17: 1067-1071.
9. PAVAN, L., V. TSATSARIS, A. HERMOUET, et al. 2004. Oxidized low-density lipoproteins inhibit trophoblastic cell invasion. J. Clin. Endocrinol. Metab. 89: 1969-1972.
10. HOLERS, V.M., G. GIRADI, L. MO, et al. 2002. Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J. Exp. Med. 195: 211-220.
11. CARBILLON, L., M. UZAN & S. UZAN. 2000. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet. Gynecol. Surv. 55: 574-581.
12. CARBILLON, L., J.C. CHALLIER, S. ALOUINI, et al. 2001. Uteroplacental circulation development: Doppler assessment and clinical importance. Placenta 22: 795-799.
13. KUTTEH, W.H. 1996. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low dose aspirin alone. Am. J. Obstet. Gynecol. 174: 1584-1589.
14. RAI, R., H. COHEN, M. DAVE, et al. 1997. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 314: 253-257.
15. FARQUHARSON, R.G., S. QUENBY & M. GREAVES. 2002. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet. Gynecol. 100: 408-413.
16. MEIZNER, I., M. KATZ & F. PRESS. 1998. Assessment of utero-placental blood flow velocity waveforms in a pregnant patient with systemic lupus erythematosus. J. Clin. Ultrasound 16: 55-57
17. BLUMENFELD, Z., Z. WEINER, M. LORBER, et al. 1991. Anticardiolipin antibodies in patients with recurrent pregnancy wastage: treatment and uterine blood flow. Obstet. Gynecol. 78: 584-589.
18. BAR, J., R. MASHIAH, B. COHEN-SACHER, et al. 2001. Effect of thromboprophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb. Res. 101: 235-241.
19. BENIFLA, J.L., C. TCHOBROUTSKY, M. UZAN, et al. 1992. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and antiphospholipid syndrome. Fetal. Diagn. Ther. 7: 195-202.
20. CARUSO, A., S. DE CAROLIS, S. FERRAZZANI, et al. 1993. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet. Gynecol. 82: 970-977.
21. FARRELL, T. & T. DAWSON. 2001. Can uterine artery Doppler velocimetry predict adverse pregnancy outcome in women with antiphospholipid syndrome? Acta Obstet. Gynecol. Scand. 80: 609-610.
22. VENKAT-RAMAN, N., M. BACKOS, T.G. TEOH, et al. 2001. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet. Gynecol. 98: 235-242.
23. LE THI HUONG, D., B. WECHSLER, D. VAUTHIER-BROUZES, et al. 2006. The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome. Rheumatology 45: 332-338.
24. BATS, A.S., V. LEJEUNE, E. CYNOBER, et al. 2004. Antiphospholipid syndrome and second- or third-trimester fetal death: follow-up in the next pregnancy. Eur. J. Obstet. Gynecol. Rep. Biol. 114: 125-129.